Procter & Gamble Stock Price, News & Analysis

Pampers has launched an upgraded version of its Pure diapers, now featuring a plant-based liner enriched with shea butter, following a survey revealing that 80% of moms prefer such enhancements. The new diapers are hypoallergenic and free from harmful additives, ensuring skin safety. Pampers Pure is backed by clinical evidence and meets safety standards, with stylish new prints available in sizes N through 6. Pampers remains the #1 Pediatrician Recommended Brand. The new product aligns with parent preferences for quality and safety in diapering.

The Procter & Gamble Company (NYSE: PG) has announced the pricing of its debt tender offer for several debt securities. The tender offer, initiated on October 13, 2020, received valid tenders totaling approximately $1.98 billion as of the Early Tender Deadline on October 26, 2020. P&G will accept all validly tendered amounts, with total considerations varying by security. The tender offer will expire on November 9, 2020. The settlement date for accepted securities is expected on October 29, 2020. Citigroup, Deutsche Bank, and Goldman Sachs are managing the offer.

The Procter & Gamble Company (NYSE: PG) announced early results of its debt tender offer, increasing the maximum purchase price from $1.5 billion to approximately $2.0 billion. The tender offer allows P&G to buy select debt securities, with an Early Tender Deadline already passed. Validly tendered securities will not be withdrawn, and the final acceptance amounts depend on priority levels established. The tender offer will conclude by November 9, 2020, barring extensions. Citigroup, Deutsche Bank, and Goldman Sachs act as dealer managers for the offer.

Procter & Gamble (NYSE:PG) has received an unsolicited mini-tender offer from Mason Bell LLC to buy up to 50,000 shares at $106.00 each, significantly below the market closing price of $142.38 on October 23, 2020. P&G advises shareholders against accepting this offer, highlighting its low valuation and lack of investor protections typically associated with larger tender offers. The company stresses that investors should consult market prices and exercise caution, especially as the offer could terminate if share prices drop below the bid before expiration on December 2, 2020.

The EPA has approved Microban 24 Sanitizing Spray as effective against SARS-CoV-2, the virus responsible for COVID-19. The product was tested under strict EPA guidelines, proving it can kill the virus within 60 seconds. Alongside its initial effectiveness, Microban 24 offers continued protection against 99.9% of bacteria and viruses for up to 24 hours. Launched in February, it aims to enhance sanitization in homes, especially during flu season. The approval reinforces its position on the EPA's List N for products effective against tougher viruses.

Secret® Deodorant has pledged $1 million to the Professional Women’s Hockey Players Association (PWHPA), marking the largest corporate investment in women’s professional hockey in North America. This commitment addresses the disparities faced by female athletes exacerbated by the COVID-19 pandemic. The funding will support the Secret® Dream Gap Tour, featuring top players competing for cash prizes and promoting visibility for women’s hockey. The initiative aims to create equitable opportunities in sports for women while advocating for a sustainable professional league.

Oral-B has launched an initiative to enhance oral health in the U.S. by promoting its new electric toothbrush, Oral-B iO, while providing $1 million in dental care products to high-risk individuals through the Dental Lifeline Network. The program includes partnerships with dentists nationwide and notable personalities to raise awareness of oral health. The Oral-B iO, developed over six years, has received the ADA seal of approval, aiming to offer users a professional-clean feel at home. Special promotions for the toothbrush are available through the end of October.

The Procter & Gamble Company (NYSE:PG) reported a strong first quarter for fiscal year 2021, with net sales of $19.3 billion, up 9% year-over-year. Diluted net earnings per share increased 20% to $1.63. Organic sales growth also reached 9%, driven by volume and pricing increases across various segments. The company returned $4 billion to shareholders through dividends and stock repurchases. P&G has raised its fiscal 2021 sales growth outlook to 3-4% and core EPS growth to 5-8%.